These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 9264349)
21. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors. Can B; Sökmensüer C Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191 [TBL] [Abstract][Full Text] [Related]
22. The c-erb B-2 proto-oncogene in human pancreatic cancer. Hall PA; Hughes CM; Staddon SL; Richman PI; Gullick WJ; Lemoine NR J Pathol; 1990 Jul; 161(3):195-200. PubMed ID: 2202801 [TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices. Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163 [TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of plasma prolactin in breast cancer: comparison with the expression of c erb B-2 oncoprotein. Bhatavdekar JM; Patel DD; Sherbet GV; Giri DD; Karelia NH; Vora HH; Shah NG; Suthar TP; Nadkarni SP; Balar DB Eur J Surg Oncol; 1993 Oct; 19(5):409-13. PubMed ID: 8104829 [TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis. Vora HH; Shah NG; Patel DD; Trivedi TI; Chikhlikar PR J Surg Oncol; 2003 Jan; 82(1):34-50. PubMed ID: 12501167 [TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical analysis of expression of molecular biologic factors in intraductal papillary-mucinous tumors of pancreas--diagnostic and biologic significance. Islam HK; Fujioka Y; Tomidokoro T; Sugiura H; Takahashi T; Kondo S; Katoh H Hepatogastroenterology; 1999; 46(28):2599-605. PubMed ID: 10522048 [TBL] [Abstract][Full Text] [Related]
27. Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast. Selim AG; El-Ayat G; Wells CA Virchows Arch; 2002 Nov; 441(5):449-55. PubMed ID: 12447674 [TBL] [Abstract][Full Text] [Related]
28. Mycosis fungoides: expression of C-myc p62 p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus. Kanavaros P; Ioannidou D; Tzardi M; Datseris G; Katsantonis J; Delidis G; Tosca A Pathol Res Pract; 1994 Sep; 190(8):767-74. PubMed ID: 7831152 [TBL] [Abstract][Full Text] [Related]
29. Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomas. de Krijger RR; van der Harst E; van der Ham F; Stijnen T; Dinjens WN; Koper JW; Bruining HA; Lamberts SW; Bosman FT J Pathol; 1999 May; 188(1):51-5. PubMed ID: 10398140 [TBL] [Abstract][Full Text] [Related]
30. Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis. Slesak B; Harlozinska A; Porebska I; Bojarowski T; Lapinska J; Rzeszutko M; Wojnar A Anticancer Res; 1998; 18(4A):2727-32. PubMed ID: 9703936 [TBL] [Abstract][Full Text] [Related]
31. Molecular genetics of gastroenteropancreatic neuroendocrine tumors. Toumpanakis CG; Caplin ME Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492 [TBL] [Abstract][Full Text] [Related]
32. Relationship between AgNORs, MIB-1 and oncogene expression in male breast carcinoma and papillary superficial bladder neoplasm. Pich A; Margaria E; Chiusa L; Bortolin P; Palestro G Oncol Rep; 2003; 10(5):1329-35. PubMed ID: 12883702 [TBL] [Abstract][Full Text] [Related]
33. Correlation of proliferating cell nuclear antigen and bcl-2 expression with tumor front grading and metastasis in laryngeal squamous cell carcinoma. Boran C; Yildiz L; Kandemir B; Karagoz F; Baris S; Aydin O Neoplasma; 2003; 50(2):139-43. PubMed ID: 12740649 [TBL] [Abstract][Full Text] [Related]
34. Bcl-2 expression in breast cancer: a comparative study at the mRNA and protein level. Martínez-Arribas F; Alvarez T; Del Val G; Martín-Garabato E; Núñez-Villar MJ; Lucas R; Sánchez J; Tejerina A; Schneider J Anticancer Res; 2007; 27(1A):219-22. PubMed ID: 17352236 [TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors. Lubomierski N; Kersting M; Bert T; Muench K; Wulbrand U; Schuermann M; Bartsch D; Simon B Cancer Res; 2001 Aug; 61(15):5905-10. PubMed ID: 11479232 [TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical studies on c-erbB-2 oncoprotein expression in paraffin embedded tissues in invasive and non-invasive human breast lesions. Pechoux C; Chardonnet Y; Noël P Anticancer Res; 1994; 14(3B):1343-60. PubMed ID: 7915095 [TBL] [Abstract][Full Text] [Related]
37. DNA methyltransferases 1, 3a, and 3b overexpression and clinical significance in gastroenteropancreatic neuroendocrine tumors. Rahman MM; Qian ZR; Wang EL; Yoshimoto K; Nakasono M; Sultana R; Yoshida T; Hayashi T; Haba R; Ishida M; Okabe H; Sano T Hum Pathol; 2010 Aug; 41(8):1069-78. PubMed ID: 20381114 [TBL] [Abstract][Full Text] [Related]
38. Strong c-Jun immunoreactivity is associated with apoptotic cell death in human tumors of the central nervous system. Ferrer I; Seguí J; Olivé M Neurosci Lett; 1996 Aug; 214(1):49-52. PubMed ID: 8873129 [TBL] [Abstract][Full Text] [Related]
39. Induction of lung carcinogenesis in AKR-mice by N-nitrosodiethylamine/phenobarbitone, associated with high expression of c-myc and c-jun oncoproteins. Giri RK; Baral RN; Das BR Cancer Lett; 1997 Jan; 112(1):57-63. PubMed ID: 9029169 [TBL] [Abstract][Full Text] [Related]